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Reading the lay press in Brazil daily reveals both the importance and the difficulties 
of clinical research in the Twenty-First century in our 
country. The approval by the Congress of the so-called 
“cancer pill’, which is phosphoethanolamine-based and 
the doubts regarding arboviruses are two of the most 
emblematic challenges faced by clinical research in our 
field. It will always be about understanding the historical, 
circumstantial and structural limiting facts that prevent 
the full development of clinical research from happening.
Defining “clinical research”
The first point to be discussed is precisely the term 
“clinical research”. By definition, clinical research means 
there is at least one human is being studied in a scientific 
project. It may have an observational origin only, as in the 
description of a clinical case, or it may be an intervention 
with tens of thousands of participants as in the modern 
clinical trials. However, in recent decades, the term “clinical 
research” has erroneously become synonymous with 
therapeutic trials with new (or old) drugs. This confusion of 
terms was not beneficial for the establishment of a culture 
of research in humans in Brazil. The second important 
point is to present what would the primary scientific 
research designs in the medical field be. Let us illustrate 
it didactically with studies related to high blood pressure. 
1) Clinical case or case reports: The first is the 
description of a clinical case or series of cases in a situation 
of outpatient care, as the description of albuminuria 
syndrome by R. Bright was in 1836, even before the 
creation of sphygmomanometers1.
2) Physical and chemical or biochemical studies: 
A second example would be all the experiments that do 
not involve any living being, for example, the accepted 
proposal to shape and build a molecule to block the function 
of the autonomic nervous system, which was the case of 
the creation of the beta-blockers by James Black in 19622. 
3) experiments in animals: The third type of 
research involves animals in controlled experiments such 
as the traditional Goldblatt experiment in 1934, in which 
he clamped the renal artery unilaterally and discovered the 
association between the reduction in renal blood flow and 
high blood pressure and, later, renin.
4) Observational or cohort studies: The fourth 
type is only observational in a large sample of people for 
a long time, as it was for high blood pressure as a risk 
factor for cerebrovascular and coronary heart disease. The 
best example is the Framingham Heart Study, which was 
established in 1948 in the American city that gives this 
study its name and has since then opened a new universe 
of knowledge regarding cardiovascular risk factors4.
5) Interventional studies or clinical trials: As 
what has been happening with several diets and drugs tests 
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as well as other actions to discover which of them would 
be effective to lower the blood pressure in hypertensive 
patients, as in the recent SPRINT showing new ideal limits 
for lowering blood pressure5.
6) Secondary base studies: they can be demographic 
studies, such as the identification of the evolution of 
mortality caused by high blood pressure-related diseases6. 
HISTORY 
For decades, the Medical Sciences in Brazil have 
been a combination of experimental studies using animals 
and descriptions of cases or clinical series. This polarity 
reflected the division between “primary subjects” and 
“clinical subjects” in medical schools. During decades, this 
dichotomy was only the effect of splitting undergraduate 
medical between basic and clinical disciplines. Further, 
this dichotomous structure to teaching medicine became 
the cause a medical course divided between biology and 
medicine. The separation between these two areas has 
expanded over time, reducing the much-needed dialogue 
between science and medicine. The distance between who 
is practicing the “pure science” and who has involved in 
the “practical medicine” is the source of two recurrent 
problems observed reading publications, thesis or papers, 
from a medical school. One is the lack of statistical power 
for the description of a small number of surgical and non-
surgical interventions. Another problem is from studies 
using animals without a great research question derived 
from the clinical practice. Although they can be designed 
with scientific rigor, the generalization of these results has 
been very low. 
In the last decades, however, there has been a 
movement of progressive improvement in research in 
humans with the incorporation of practices coming from 
epidemiology and its basic designs, cohort, case-control, 
transversal that allowed the clinical trials to have a 
stable structure. Another aspect leading to considerable 
improvement in clinical research was the dissemination 
of the ethical principles of experimentation in humans that 
began at the end of World War II and which materialized 
in Brazil with the resolution 196/96 of the National Health 
Council, which is the regulatory milestone for clinical 
studies in the country. 
However, the challenges to the full development of 
clinical research are still the lack of tradition and culture 
of all individuals involved in accepting that science is 
paramount to an effective and appropriate clinical practice. 
The greatest example of our low cultural level was the 
approval of phosphoethanolamine by the Congress, a 
farce in which the Universidade de São Paulo was the 
protagonist through a unit without any affinity with the 
medical field and through Professors without any tradition 
in clinical research.
The current contribution of the USP Faculty of Medicine
Despite the huge disappointment, it was to see the 
name of the Universidade de São Paulo involved in such an 
unhappy episode of the “cancer pill,” the remaining schools 
and institute of USP – have shown numerous studies of 
high quality regarding clinical research. To mention only 
the current example of FMUSP and using the classification 
presented above we can provide some examples of excellent 
contributions from Casa de Arnaldo.
1) Clinical case or case reports: the Clinical 
Medicine Division of the University Hospital publishes 
an electronic magazine of enormous importance, “Autopsy 
and Cases Reports”, whose documentary value is scientific 
and educational7. The Institute of Psychiatry has a research 
line on images in the field of Alzheimer’s with paramount 
results for better knowing this and other diseases8.
2) Experiments in animals: research related to cancer 
with murine models performed at the LIM-Oncology, which 
become hypotheses to be developed at the Cancer Institute9. 
3) Observational or cohort studies: the Clinical 
and Epidemiological Research Center based at University 
Hospital coordinates the largest study on cardiovascular 
diseases and diabetes in the southern hemisphere. The 
Brazilian Longitudinal Study of the Adult Health, ELSA 
- Brazil (Estudo Longitudinal de Saúde do Adulto ELSA - 
Brasil) with 15105 participants being monitored since 2008 
with more than 100 original papers published and intense 
international collaboration10. 
4) interventional studies or clinical trials: the 
comparison of electrical stimulation in depression that 
resulted in an article in “The New York Times”, which was 
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conducted at the Clinical and  Epidemiologic Research 
Center of the University Hospital and is the most cited study 
in the field11. The Heart Institute created the “Medicine, 
Angioplasty, Surgery Study” (MASS), a clinical trial for 
angina of huge impact and with five developments, all of 
the vast importance in the scope of global cardiology12. 
5) Secondary base studies: the Preventive Medicine 
Department published a necessary critical evaluation of 
several studies and demographic bases linking depression 
to violent behavior13.  
CONCLUSION
Clinical research in Brazil is still in its early days 
and can grow greatly in the next decades not only with 
funding but mainly to the improvement of scientific culture 
in the country.
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